These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 3707157)
1. [Criteria for the determination of the efficacy of cancer chemo-radiotherapy in primary and metastatic lung cancer]. Niitani H Gan To Kagaku Ryoho; 1986 May; 13(5):1999-2006. PubMed ID: 3707157 [No Abstract] [Full Text] [Related]
2. [Management of non-small-cell lung carcinoma (NSCLC) of stage III B]. Koukourakis M Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S33-6. PubMed ID: 11924241 [No Abstract] [Full Text] [Related]
3. [Therapeutic management of non-small-cell lung carcinoma (NSCLC) of stage III A]. Mornex F Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S29-32. PubMed ID: 11924239 [No Abstract] [Full Text] [Related]
4. Metastatic lung cancer involving the vulva: two new cases and literature review. McAlinden J; Caruso V; Hammond I Aust N Z J Obstet Gynaecol; 2011 Apr; 51(2):175-6. PubMed ID: 21466522 [TBL] [Abstract][Full Text] [Related]
13. The relationship of experimental, theoretical and clinical studies of alternating chemotherapy and radiotherapy in the management of lung cancer. Looney WB; Hopkins HA Antibiot Chemother (1971); 1988; 41():35-47. PubMed ID: 3072918 [No Abstract] [Full Text] [Related]
15. Induction chemotherapy before chemoradiation in locally advanced non-small-cell lung cancer: failure after failure, again and again. Jeremic B; Koning C J Clin Oncol; 2008 Apr; 26(10):e1-2. PubMed ID: 18375883 [No Abstract] [Full Text] [Related]
16. [Pay close attention to standardization of the treatment of primary liver cancer]. Ye SL Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):401-2. PubMed ID: 19645133 [No Abstract] [Full Text] [Related]
17. Second IASLC Workshop on Combined Radiotherapy and Chemotherapy Modalities in Lung Cancer. Biological basis of combined therapy. Souhami RL; Brodin O; Duchesne G; Goldie J; Green M; Kies M; Mattson K; Mulshine J; Saijo N; Saunders M Lung Cancer; 1994 Mar; 10 Suppl 1():S3-5. PubMed ID: 8087524 [No Abstract] [Full Text] [Related]
18. Unusual tumor response and toxicity from radiation and concurrent erlotinib for non-small-cell lung cancer. Nanda A; Dias-Santagata DC; Stubbs H; O'Hara CJ; Zaner KS; Lynch TJ; Willers H Clin Lung Cancer; 2008 Sep; 9(5):285-7. PubMed ID: 18824451 [TBL] [Abstract][Full Text] [Related]
19. Combined modality therapy of non-small cell lung cancers. Juretic A; Sobat H; Samija M Ann Oncol; 1999; 10 Suppl 6():93-8. PubMed ID: 10676559 [TBL] [Abstract][Full Text] [Related]
20. Controversies in the nonsurgical treatment of stage III non-small cell lung cancer. Hazuka MB; Bunn PA Am Rev Respir Dis; 1992 Apr; 145(4 Pt 1):967-77. PubMed ID: 1313216 [No Abstract] [Full Text] [Related] [Next] [New Search]